McKesson Corporation $MCK Shares Acquired by DSG Capital Advisors LLC

DSG Capital Advisors LLC lifted its holdings in McKesson Corporation (NYSE:MCK) by 20.0% in the 3rd quarter, Holdings Channel reports. The firm owned 4,134 shares of the company’s stock after acquiring an additional 690 shares during the period. DSG Capital Advisors LLC’s holdings in McKesson were worth $3,530,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Nvwm LLC boosted its position in shares of McKesson by 933.3% during the third quarter. Nvwm LLC now owns 31 shares of the company’s stock valued at $26,000 after buying an additional 28 shares during the last quarter. Delos Wealth Advisors LLC purchased a new position in McKesson in the 2nd quarter worth about $27,000. Trellis Wealth Advisors LLC purchased a new position in McKesson in the 3rd quarter worth about $32,000. GK Wealth Management LLC purchased a new position in McKesson in the 3rd quarter worth about $38,000. Finally, Curry Webb Wealth Management LLC purchased a new position in McKesson in the 3rd quarter worth about $38,000. 85.07% of the stock is owned by institutional investors.

Insider Buying and Selling at McKesson

In other news, CAO B Jr sold 111 shares of the company’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total value of $98,950.95. Following the completion of the sale, the chief accounting officer directly owned 521 shares in the company, valued at $464,445.45. This represents a 17.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Francisco Fraga sold 650 shares of the firm’s stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $1,102.96, for a total value of $716,924.00. Following the completion of the transaction, the executive vice president directly owned 4,414 shares in the company, valued at approximately $4,868,465.44. This represents a 12.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,161 shares of company stock valued at $2,242,515 over the last 90 days. 0.06% of the stock is currently owned by company insiders.

McKesson Trading Up 2.3%

Shares of NYSE MCK opened at $1,083.95 on Wednesday. McKesson Corporation has a 12-month low of $723.68 and a 12-month high of $1,121.50. The firm has a market capitalization of $125.15 billion, a price-to-earnings ratio of 24.84, a price-to-earnings-growth ratio of 1.79 and a beta of 0.27. The firm has a 50 day moving average of $945.38 and a 200 day moving average of $870.63.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, November 4th. The company reported $11.68 earnings per share for the quarter, topping the consensus estimate of $10.72 by $0.96. McKesson had a net margin of 1.12% and a negative return on equity of 202.94%. The business had revenue of $110.96 billion for the quarter, compared to the consensus estimate of $109.90 billion. During the same period last year, the firm earned $9.86 earnings per share. The company’s quarterly revenue was up 7.5% on a year-over-year basis. Sell-side analysts predict that McKesson Corporation will post 46.16 EPS for the current year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be given a dividend of $0.94 per share. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.3%. McKesson’s payout ratio is presently 9.67%.

Analyst Upgrades and Downgrades

MCK has been the topic of a number of recent analyst reports. UBS Group raised their price target on shares of McKesson from $1,200.00 to $1,250.00 and gave the company a “buy” rating in a report on Thursday, November 5th. Leerink Partners lifted their price objective on McKesson from $1,070.00 to $1,200.00 and gave the stock an “outperform” rating in a report on Thursday, November 5th. Weiss Ratings upgraded McKesson from a “buy (b)” rating to a “buy (b+)” rating in a research report on Monday. Argus increased their target price on McKesson from $850.00 to $970.00 and gave the company a “buy” rating in a report on Thursday, September 3rd. Finally, Evercore reissued an “outperform” rating and issued a $950.00 target price (down from $1,000.00) on shares of McKesson in a research report on Thursday, August 6th. Fifteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, McKesson presently has a consensus rating of “Moderate Buy” and a consensus target price of $1,040.29.

McKesson Profile

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.